Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  New Zealand Stock Exchange  >  Fisher & Paykel Healthcare Corporation Limited    FPH   NZFAPE0001S2

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

(FPH)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector news

Australia shares rise as Fed signals more support; iron giants boost

share with twitter share with LinkedIn share with facebook
07/29/2020 | 09:45pm EDT

* Rio, Fortescue shine as results beat estimates

* Macquarie says Q1 results to be lower, gives no outlook

* Tech stocks mark best day in more than a week

July 30 (Reuters) - Australian shares rose on Thursday as the U.S. Federal Reserve reiterated its plans to keep interest rates near-zero for as long as it takes to revive the economy, while strong performance from domestic iron ore miners also boosted stocks.

The S&P/ASX 200 index was up 0.7% at 6,045.3 by 0106 GMT.

Fed policymakers renewed their pledge to utilise all means at their disposal to set the virus-hit economy on the path to recovery but warned that the outlook would depend on the course the virus takes.

Australian mining index also drew support from better-than-expected earnings and production numbers from iron ore giants.

Heavyweights Rio Tinto and Fortescue Metals Group beat expectations to post solid results as demand recovers in China for the steel-making material.

Financials also rose 1% with the "Big Four" banks all trading in positive territory.

Lender Macquarie Group rose 2.4% despite saying its first-quarter profit would be lower than last year and left investors in the dark with no earnings forecast for fiscal 2021.

Meanwhile, Commonwealth Bank of Australia said it would allocate $216 million as remediation to customers affected by widespread misconduct in its aligned advice businesses.

As investors' place optimistic bets on impending results from U.S. tech giants, Australian technology stocks followed suit to add as much as 2.5% and mark their best session in more than a week.

Buy-now-pay-later firm Afterpay tacked on 2.7%, while accounting software company Xero gained 1.4%.

New Zealand's benchmark S&P/NZX 50 index gained 0.6% to 11,663.87.

Fisher & Paykel Healthcare Corp and Ryman Healthcare gained 1.1% and 1.5%, respectively.

(Reporting by Arpit Nayak in Bengaluru, Editing by Sherry Jacob-Phillips)

Stocks mentioned in the article
ChangeLast1st jan.
AFTERPAY LIMITED 2.44% 75.95 End-of-day quote.159.39%
COMMONWEALTH BANK OF AUSTRALIA 3.01% 66.13 End-of-day quote.-17.23%
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED 1.96% 33.75 End-of-day quote.52.03%
FORTESCUE METALS GROUP LIMITED -0.25% 15.91 End-of-day quote.48.83%
MACQUARIE GROUP LIMITED -0.05% 121.67 End-of-day quote.-11.74%
RIO TINTO GROUP 0.83% 98 End-of-day quote.-2.39%
RYMAN HEALTHCARE LIMITED 0.29% 13.86 End-of-day quote.-15.13%
S&P/ASX 200 1.51% 5964.9 Real-time Quote.-12.09%
XERO LIMITED 0.37% 97.63 End-of-day quote.22.04%
share with twitter share with LinkedIn share with facebook
All news about FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
09/22Australia shares end lower as rising COVID-19 cases stoke lockdown worries
RE
09/21Australia shares hit over 2-month low as miners drag; U.S. stimulus woes weig..
RE
09/20Australia shares slip as virus cases resurge in Europe; NZ lower
RE
09/10Australia shares hit over 2-month low as tensions with China mount
RE
09/03Australia shares fall sharply on Wall Street tech sell-off
RE
09/02Australia shares follow Wall Street higher on recovery, stimulus hopes
RE
08/31Australia shares hit four-week low ahead of cenbank decision
RE
08/30Australia shares wobble ahead of cenbank rate decision; NZ falls
RE
08/26Australia shares slip on rising virus death toll
RE
08/21FISHER & PAYKEL HEALTHCARE : 2020 Annual Shareholders' Meeting Results
PU
More news
Financials
Sales 2021 1 647 M 1 079 M 1 079 M
Net income 2021 397 M 260 M 260 M
Net cash 2021 66,5 M 43,6 M 43,6 M
P/E ratio 2021 48,9x
Yield 2021 1,17%
Capitalization 19 432 M 12 720 M 12 726 M
EV / Sales 2021 11,8x
EV / Sales 2022 11,6x
Nbr of Employees 4 751
Free-Float 99,8%
Chart FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Duration : Period :
Fisher & Paykel Healthcare Corporation Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 9
Average target price 28,51 NZD
Last Close Price 33,75 NZD
Spread / Highest target 11,4%
Spread / Average Target -15,5%
Spread / Lowest Target -40,1%
EPS Revisions
Managers
NameTitle
Lewis George Gradon Chief Executive Officer, Director & MD
Scott Andrew St. John Chairman
Lyndal York Chief Financial Officer
Andrew Robert Donald Somervell Vice President-Products & Technology
Nicholas Fourie VP-Information & Communication Technology
Sector and Competitors
1st jan.Capitalization (M$)
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED52.03%12 440
ABBOTT LABORATORIES16.19%178 682
MEDTRONIC PLC-10.74%136 129
BECTON, DICKINSON AND COMPANY-18.68%64 107
HOYA CORPORATION11.72%42 186
BAXTER INTERNATIONAL INC.-5.88%39 840